Roswell Park Cancer Institute (RPCI) — Buffalo, New York

Roswell Park Cancer Institute (RPCI) is a clinical research site located in Buffalo, New York, United States 14263.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Roswell Park Cancer Institute (RPCI) has participated in 1 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Roswell Park Cancer Institute (RPCI)?

Roswell Park Cancer Institute (RPCI) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Roswell Park Cancer Institute (RPCI) conducted?

Roswell Park Cancer Institute (RPCI) has 1 clinical trials on record. Their work covers Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation.

Is Roswell Park Cancer Institute (RPCI) accredited by Crixeo Health?

Roswell Park Cancer Institute (RPCI) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Roswell Park Cancer Institute (RPCI)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.